← Evidence map

ArticleCancers2025

Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma Network.

Christoph Blazejak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma Network. | Socratic